Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat

Go back to Protalix BioTherapeutics (PLX) Tops Q1 EPS by 40c, Revenues Beat
PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) Delayed: 2.09 +0.04 (1.95%)
Previous Close $2.05    52 Week High $1.11 
Open $2.07    52 Week Low $0.41 
Day High $2.11    P/E N/A 
Day Low $2.06    EPS $-0.29 
Volume 249,040